Influence of radical prostatectomy on serum hormone levels

Journal of Urology

Volumn 160, Issue 2, 1998, Pages 449-453

  Miller, Leslie R ^a   Partin, Alan W ^a   Chan, Daniel W ^a   Bruzek, Debra J ^a   Dobs, Adrian S ^a   Epstein, Jonathan I ^a   Walsh, Patrick C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gonadotropins; Hormones; Prostate specific antigen; Prostatectomy; Testosterone

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; HORMONE; LUTEINIZING HORMONE; PROLACTIN; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER LOCALIZATION; GONADOTROPIN RELEASE; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIBIDO; MAJOR CLINICAL STUDY; MALE; NEGATIVE FEEDBACK; PHLEBOTOMY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEXUAL DYSFUNCTION; SEXUAL FUNCTION;

EID: 0032324294     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62922-7     Document Type: Article

References (22)

1. Rosner, W., Khan, M. S., Breed, C. N., Fleisher, U. and Bradlow, H. L.: Plasma steroid-binding proteins in the cysts of gross cystic disease in the breast. J. Clin. Endocr. Metab., 61: 200, 1985.
2. Carter, H. B., Pearson, J. D., Metter, E. J., Chan, D. W., Andres, R., Fozard, J. L., Rosner, W. and Walsh, P. C.: Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate, 27: 25, 1995.
3. Robinson, M. R. G. and Thomas, B. S.: Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma. Brit. Med. J., 4: 391, 1971.
4. Meikle, A. W., Smith, J. A. and West, D. W.: Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. Prostate, 6: 121, 1985.
5. Drafta, D., Proca, E., Zamfir, V., Schinder, A. E., Neacsu, E. and Stroe, E.: Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate. J. Steroid Biochem., 17: 689, 1982.
6. Zumoff, B., Levin, J., Strain, G. W., Rosenfeld, R. S., O'Connor, J., Freed, S. Z., Kream, J., Whitmore, W. S., Fukushima, D. K. and Hellman, L.: Abnormal levels of plasma hormones in men with prostate cancer: evidence toward a "two-disease" theory. Prostate, 3: 579, 1982.
7. Hammond, G. L., Kontturi, M., Vihko, P. and Vihko, R.: Serum steroids in normal males and patients with prostatic diseases. Clin. Endocr., 9: 113, 1978.
8. Bartsch, W., Becker, H., Pinkenburg, F. A. and Krieg, M.: Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH). Acta Endoer., 90: 727, 1979.
9. Stege, R. and Carlstrom, K.: Testicular and adrenocortical function in healthy men and in men with benign prostatic hyperplasia. J. Steroid Biochem. Mol. Biol., 42: 357, 1992.
10. Ishimaru, T., Pages, L. and Horton, R.: Altered metabolism of androgens in elderly men with benign prostatic hyperplasia. J. Clin. Endocr., 45: 695, 1977.
11. Lukkarinen, O.: Total and SHBG-bound testosterone and 5 alpha-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma. Brit. J. Urol., 52: 377, 1980.
12. Lukkarinen, O., Hammond, G. L., Kontturi, M. and Vihko, R.: Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma. Scand. J. Urol. Nephrol., 14: 225, 1980.
13. Ghanadian, R., Puah, C. M., Williams, G., Shah, P. J. and McWhinney, N.: Suppressive effects of surgical stress on circulating androgens during and after prostatectomy. Brit. J. Urol., 53: 147, 1981.
14. Hammond, G. L., Lukkarinen, O., Vihko, P., Kontturi, M. and Vihko, R.: The hormonal status of patients with benign prostatic hypertrophy: FSH, LH, TSH and prolactin responses to releasing hormones. Clin. Endocr., 10: 545, 1979.
15. Ghosh, P. K., Ghosh, D., Ghosh, P. and Chaudhuri, A.: Effects of prostatectomy on testicular androgenesis and serum levels of gonadotropins in mature albino rats. Prostate, 26: 19, 1995.
16. Schaison, G., Renoir, M., Lagoguey, M. and Mowszowicz, I.: On the role of dihydrotestosterone in regulating luteinizing hormone secretion in man. J. Clin. Endocr. Metab., 51: 1133, 1980.
17. Gormley, G. J., Stoner, E., Bruskewitz, R. C., Imperato-McGinley, J., Walsh, P. C., McConnell, J. D., Andriole, G. L., Geller, J., Bracken, B. R., Tenover, J. S. and the Finasteride Study Group: The effect of finasteride in men with benign prostatic hyperplasia. New Engl. J. Med., 327: 1185, 1992.
18. 1. Cancer Res., 53: 4855, 1993.
19. Risbridger, G. P., Thomas, T., Gurusinghe, C. J. and McFarlane, J. R.: Inhibin-related proteins in rat prostate. J. Endocr., 149: 93, 1996.
20. Ying, S.-Y., Zhang, Z. and Huang, G.: Expression and localization of inhibin/activin subunits and activin receptors in the normal rat prostate. Life Sci., 60: 397, 1997.
21. Phadke, M. A., Vanage, G. R. and Sheth, A. R.: Circulating levels of inhibin, prolactin, TSH, LH, and FSH in benign prostatic hypertrophy before and after tumor resection. Prostate, 10: 115, 1987.
22. Reiter, E., McNamara, M., Closset, J. and Hennen, G.: Expression and functionality of luteinizing hormone/chorionic gonadotropin receptor in the rat prostate. Endocrinology, 136: 917, 1995.